What is he best known for?
The fields of study he is best known for:
Ed Harlow spends much of his time researching Molecular biology, Retinoblastoma protein, Cell biology, Retinoblastoma-Like Protein p107 and Cell cycle.
He has included themes like Histone H2A, Histone H1, Virus, Epitope and Monoclonal antibody in his Molecular biology study.
The Retinoblastoma protein study combines topics in areas such as E2F1, E2F, Tumor suppressor gene, Retinoblastoma-like protein 1 and Gene product.
His Cell biology study incorporates themes from Cyclin-dependent kinase, Cyclin A and Binding site.
His Retinoblastoma-Like Protein p107 study integrates concerns from other disciplines, such as Retinoblastoma and Transformation.
His Cell cycle study combines topics from a wide range of disciplines, such as Cell culture, Kinase and Cell growth.
His most cited work include:
- Antibodies: A Laboratory Manual (20645 citations)
- Using Antibodies: A Laboratory Manual (2641 citations)
- The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product (2509 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Molecular biology, Cell biology, Retinoblastoma protein, Biochemistry and E2F.
His study in Molecular biology is interdisciplinary in nature, drawing from both Cell culture, Immunoprecipitation, Retinoblastoma-Like Protein p107, Antigen and Monoclonal antibody.
In his research, Antigen retrieval is intimately related to Epitope, which falls under the overarching field of Monoclonal antibody.
His studies in Cell biology integrate themes in fields like Cell cycle and Cyclin-dependent kinase.
His research in Cyclin-dependent kinase intersects with topics in Cyclin-dependent kinase 1, Cyclin D1, Peptide sequence and Cyclin.
His study looks at the relationship between Retinoblastoma protein and fields such as Retinoblastoma-like protein 1, as well as how they intersect with chemical problems.
He most often published in these fields:
- Molecular biology (39.90%)
- Cell biology (25.96%)
- Retinoblastoma protein (18.27%)
What were the highlights of his more recent work (between 2002-2014)?
- Chromatography (9.62%)
- Molecular biology (39.90%)
- Biochemistry (16.35%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Chromatography, Molecular biology, Biochemistry, Antigen and Antibody.
Ed Harlow has researched Molecular biology in several fields, including Staining, Sonication, Immunoprecipitation and Cell biology.
His Cell biology research is multidisciplinary, relying on both Cell, Cell cycle, Cell growth, Cancer cell and Small hairpin RNA.
His study in E2F and Retinoblastoma protein is carried out as part of his studies in Cell cycle.
Ed Harlow combines subjects such as Epitope and Paraformaldehyde with his study of Biochemistry.
His work deals with themes such as Cancer research and Kinase, which intersect with Tumor suppressor gene.
Between 2002 and 2014, his most popular works were:
- Cyclin-dependent kinases: a family portrait (260 citations)
- A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation (245 citations)
- Kinase requirements in human cells: III. Altered kinase requirements in VHL−/− cancer cells detected in a pilot synthetic lethal screen (115 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Kinase, Cell biology, Cancer research, Small hairpin RNA and Cell cycle.
His Kinase research integrates issues from Cancer cell, Cell, Cell culture and Gene.
His Cell biology research is multidisciplinary, incorporating elements of Eukaryotic DNA replication, Complementary DNA, Molecular biology, GTP' and Genetic screen.
Ed Harlow undertakes interdisciplinary study in the fields of Molecular biology and Dynamin through his research.
His is involved in several facets of Cell cycle study, as is seen by his studies on E2F and Retinoblastoma protein.
His specific area of interest is Retinoblastoma protein, where Ed Harlow studies Retinoblastoma-Like Protein p107.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
